rns archives

Patent Infringement Settlement and Trading Update

26th January 2017
MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound training simulators for medical professionals, provides the following update on the patent infringement settlement and on trading for the year to 31 December 2016. Patent infringement settlement Further to the statement made by the Company on 16 December 2016, the Group subsidiaries, MedaPhor Limited and...

MedaPhor Group plc – Final Results

22nd March 2017
MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound education simulators for medical professionals, announces its preliminary results for the year ended 31 December 2016. Financial highlights Revenues increased 49% to £3.3m (2015: £2.2m) UK sales up 27%, North America sales up 7% and Rest of World sales up 166% Loss before tax...

Grant of options

4th April 2017
MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound training simulators for medical professionals, announces that Ian Whittaker, Chief Operating Officer, has today been granted 200,000 options over ordinary shares of the Company of 1 pence each (“Ordinary Shares”), pursuant to the MedaPhor Group plc EMI Share Option Scheme. The exercise price of the...

Notice of Annual General Meeting

26th April 2017
MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound training simulators for medical professionals, announces that the Company’s Annual General Meeting (“the AGM”) will be held on 23 May 2017 at 10.30 a.m. at the Company’s registered office, Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ. The Group’s 2016 Annual Report which contains the...

AGM Statement

23rd May 2017
MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound training simulators for medical professionals, will hold its Annual General Meeting today at 10.30 a.m. at the Company’s registered office, Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ. At the meeting the Chairman, Riccardo Pigliucci, will make the following statement: There are welcome signs that...


Half yearly report

31st July 2017
MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound training simulators for medical professionals, announces its unaudited half year results to 30 June 2017. Financial highlights Sales increased 63% on the comparative period to £2.1m (H1 2016: £1.3m) Cash balance at 30 June 2017 of £0.6m (31 December 2016: £1.8m) Positive progress made...

Payment of deferred consideration

10th August 2017
On 3 August 2016, MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound skills training simulators for medical professionals, announced the acquisition of Inventive Medical Limited (“IML”). Further to the terms of the acquisition, 2,325,582 new ordinary shares are being issued to The Incorporated Trustees of University College London Hospitals Charities (the “Retention Shares”). The issue...

Acquisition and Placing

19th September 2017
This announcement contains inside information which, prior to its disclosure, was inside information for the purposes of the Market Abuse Regulation (Article 7 of Regulation (EU) No 596/2014. Acquisition of deep-learning image analysis company, Intelligent Ultrasound, for up to £3.6m & Placing to raise £5.5m MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound skills training simulators...


Result of General Meeting

5th October 2017
MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders. Full announcement is available here.

Completion of Acquisition Total Voting Rights Director/PDMR Shareholding

6th October 2017
MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that following admission today of 56,477,285 new ordinary shares of 1 pence each (“Ordinary Shares”) relating to the placing to raise approximately £5.5 million and the Company’s proposed acquisition of Intelligent Ultrasound Limited for a total consideration of up to £3.6 million,...



Director Appointment

30th October 2017
MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces the appointment of Andrew Charles Barker as a Non-Executive Director effective immediately. Upon joining, Andrew will succeed David Baynes as Chairman of the Remuneration Committee, while David will retain the Chairmanship of the Company’s Audit Committee. Andrew, 59, has over 30 years’...

Innovate UK Grant Award

23rd November 2017
Conditional award to fund development of virtual reality aid for ultrasound-guided needling MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it had been awarded a conditional grant offer from Innovate UK to fund the development of a new augmented reality imaging device to improve ultrasound-guided needling. The grant of...

Archives

2018
2017
2016
2015
2014